CEO: | Stuart Ashman |
CFO: | Manprit Singh Randhawa |
Independent Non-Executive Director: | Catherine Denise Prescott |
Non-Executive Chairman: | Martin Braddock Hunt |
Non-Executive Dir: | Danielle Bekker |
Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
Phone: | +44 191 495 7325 |
Website: | http://www.skinbiotherapeutics.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BF33H870 |
Currency | UK Pounds |
Share Price | 21.21p |
Change Today | -0.039p |
% Change | -0.19 % |
52 Week High | 26.00 |
52 Week Low | 11.63 |
Volume | 674 |
Shares Issued | 173.14m |
Market Cap | £36.72m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:04 | 674 @ 21.35p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research